The US regulator has cleared use of Kerendia (finerenone) for the treatment of heart failure patients who have a left ...

It is not certain that the new Wearable Behaviour Model (WBM) AI will make it into a finished product – not least because of ...

It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...

Also cited in the complaint (PDF) are FDA Commissioner Marty Makary, NIH Director Jay Bhattacharya, who appeared alongside ...

The acquisition – which will see MSD pay $107 for each American Depository Share (ADS) in UK-headquartered Verona – is the ...

Returning for its second year, the Autoimmunity & Inflammation Partnering & Investment Summit unites over 80 on-scope and ...

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...

Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...

Apogee is pitching APG777 as a 'best-in-class' IL-13 inhibitor that could offer robust efficacy and less-frequent dosing than ...

So, what were the major themes to come out of BIO Boston 2025? Who’s getting excited about what? And – besides the obvious ...

The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...